Sobre la institución

IndieBio. Our business is to turn scientists into entrepreneurs who can save lives and save the planet (we call this “human and planetary health”). It was not that long ago (2014) that IndieBio exploded on the scene. We were the first VC to put a $2 million biotech lab in our office. We were the first accelerator to systematically write small checks into radical ideas using biology as a technology to disrupt markets outside healthcare. That portfolio of companies now has a cumulative enterprise value of nearly $4 billion — despite the average company being only 3 years old. Along the way our funds have expanded, as has our reach around the world.

Industria(s) y tecnología(s) de preferencia

Etapa de inversión

Modelo de negocio

Sin datos

Agnostic

Política de impacto

Sin datos

Deseable, pero no obligatoria

Países donde tiene oficina

Región donde invierte

National, LATAM, Asia, Africa, Europe, Oceania, North America (USA and Canada)

Requerimientos especiales para invertir

Inversiones relevantes

Beeflow, Caspr, NotCo, Michroma, Geltor, Perfect Day, Upside Foods, Mycoworks, The Every Company

Ver podcast